ResearcherNorthwestern UniversityNo recent work listed

Ada Jade Kwong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2608-7442; OpenAlex author ID A5009342045; NIH RePORTER profile ID 15648254. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper, 1 grant

Papers 1

Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma. Co-author DOI 10.1021/acsmedchemlett.1c00376 ↗

Grants 1

Synthesis, and Evaluation of Potent and Selective MEK4 Inhibitors as a Targeted Therapeutic for Metastatic Pancreatic Ductal Adenocarcinoma F31CA250353 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Thao D. Pham · 1 shared paper, 2021 · strength 0.17
- Paper Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma. DOI 10.1021/acsmedchemlett.1c00376 ↗
Karl A. Scheidt · 1 shared paper, 2021 · strength 0.17
- Paper Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma. DOI 10.1021/acsmedchemlett.1c00376 ↗
Hidayatullah G. Munshi · 1 shared paper, 2021 · strength 0.17
- Paper Rational Design, Optimization, and Biological Evaluation of Novel MEK4 Inhibitors against Pancreatic Adenocarcinoma. DOI 10.1021/acsmedchemlett.1c00376 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.